Wealth Alliance’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,917	Closed	-$264K	–	538
2024 Q1	$264K	Sell	1,917 -210	-10%	-$29K	0.03%	430
2023 Q4	$280K	Sell	2,127 -18	-0.8%	-$2.37K	0.04%	401
2023 Q3	$241K	Buy	+2,145	New	+$241K	0.04%	414